BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25761491)

  • 1. Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge.
    Navarria P; Ascolese AM; Tomatis S; Reggiori G; Clerici E; Villa E; Maggi G; Bello L; Pessina F; Cozzi L; Scorsetti M
    Cancer Res Treat; 2016 Jan; 48(1):37-44. PubMed ID: 25761491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
    Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
    Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E
    J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience.
    Guan Y; Xiong J; Pan M; Shi W; Li J; Zhu H; Gong X; Li C; Mei G; Liu X; Pan L; Dai J; Wang Y; Wang E; Wang X
    BMC Cancer; 2021 Feb; 21(1):123. PubMed ID: 33546642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
    VanderSpek L; Fisher B; Bauman G; Macdonald D
    Can J Neurol Sci; 2008 Mar; 35(1):57-64. PubMed ID: 18380278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).
    Navarria P; Minniti G; Clerici E; Tomatis S; Pinzi V; Ciammella P; Galaverni M; Amelio D; Scartoni D; Scoccianti S; Krengli M; Masini L; Draghini L; Maranzano E; Borzillo V; Muto P; Ferrarese F; Fariselli L; Livi L; Pasqualetti F; Fiorentino A; Alongi F; di Monale MB; Magrini S; Scorsetti M
    J Neurooncol; 2019 Mar; 142(1):59-67. PubMed ID: 30515706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife.
    Adachi K; Hayashi K; Kagawa N; Kinoshita M; Sumida I; Akino Y; Shiomi H; Tamari K; Suzuki O; Hirayama R; Kijima N; Isohashi F; Seo Y; Otani K; Kishima H; Ogawa K
    Anticancer Res; 2019 Jun; 39(6):2935-2940. PubMed ID: 31177132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.
    Shapiro LQ; Beal K; Goenka A; Karimi S; Iwamoto FM; Yamada Y; Zhang Z; Lassman AB; Abrey LE; Gutin PH
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):636-42. PubMed ID: 22765876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.
    Krauze AV; Peters C; Cheng J; Ning H; Mackey M; Rowe L; Cooley-Zgela T; Smart DD; Camphausen K
    Radiat Oncol; 2017 Nov; 12(1):191. PubMed ID: 29187219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Review of Re-irradiating Patients' Recurrent High-grade Gliomas.
    Klobukowski L; Falkov A; Chelimo C; Fogh SE
    Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):563-570. PubMed ID: 29891395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas.
    Minniti G; Agolli L; Falco T; Scaringi C; Lanzetta G; Caporello P; Osti MF; Esposito V; Enrici RM
    J Neurooncol; 2015 May; 122(3):559-66. PubMed ID: 25702193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
    Lee J; Ahn SS; Chang JH; Suh CO
    Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.
    Shepherd SF; Laing RW; Cosgrove VP; Warrington AP; Hines F; Ashley SE; Brada M
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):393-8. PubMed ID: 9069312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential proton boost after standard chemoradiation for high-grade glioma.
    Adeberg S; Bernhardt D; Harrabi SB; Uhl M; Paul A; Bougatf N; Verma V; Unterberg A; Wick W; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
    Radiother Oncol; 2017 Nov; 125(2):266-272. PubMed ID: 29050959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas.
    Song A; Andrews DW; Werner-Wasik M; Kim L; Glass J; Bar-Ad V; Evans JJ; Farrell CJ; Judy KD; Daskalakis C; Zhan T; Shi W
    Radiother Oncol; 2019 Mar; 132():135-141. PubMed ID: 30825962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas.
    Manabe Y; Murai T; Ogino H; Tamura T; Iwabuchi M; Mori Y; Iwata H; Suzuki H; Shibamoto Y
    Neurol Med Chir (Tokyo); 2017 Dec; 57(12):627-633. PubMed ID: 29021413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of gamma knife radiosurgery in the salvage treatment of patients with recurrent high-grade glioma.
    Elaimy AL; Mackay AR; Lamoreaux WT; Demakas JJ; Fairbanks RK; Cooke BS; Lamm AF; Lee CM
    World Neurosurg; 2013 Dec; 80(6):872-8. PubMed ID: 23403349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.
    Combs SE; Ahmadi R; Schulz-Ertner D; Thilmann C; Debus J
    J Neurooncol; 2005 Feb; 71(3):319-23. PubMed ID: 15735924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.